Samsung, in collaboration with Massachusetts General Hospital Diabetes Research Center, has initiated a study to investigate the feasibility of managing muscle loss for GLP-1 drug patients using biometric data from Galaxy Watch 8 and Samsung Health. The study addresses concerns about significant muscle mass loss associated with GLP-1 medications.
Samsung Launches Study to Prevent Muscle Loss in GLP-1 Patients Using Galaxy Watch 8
